APA

Chen S., Paveley R., Kraal L., Sritharan L., Stevens E., Dedi N., Shock A., Shaw S., Juarez M., Yeremenko N., Baeten D. & Payne A. (20210830). Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. : Journal of autoimmunity.

Chicago

Chen Sijia, Paveley Ross, Kraal Lianne, Sritharan Lathees, Stevens Elizabeth, Dedi Neesha, Shock Anthony, Shaw Stevan, Juarez Maria, Yeremenko Nataliya, Baeten Dominique and Payne Andrew. 20210830. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. : Journal of autoimmunity.

Harvard

Chen S., Paveley R., Kraal L., Sritharan L., Stevens E., Dedi N., Shock A., Shaw S., Juarez M., Yeremenko N., Baeten D. and Payne A. (20210830). Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. : Journal of autoimmunity.

MLA

Chen Sijia, Paveley Ross, Kraal Lianne, Sritharan Lathees, Stevens Elizabeth, Dedi Neesha, Shock Anthony, Shaw Stevan, Juarez Maria, Yeremenko Nataliya, Baeten Dominique and Payne Andrew. Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. : Journal of autoimmunity. 20210830.